Xtx Topco LTD Aclaris Therapeutics, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$1.01 - $1.36 $99,634 - $134,161	-98,648 Reduced 80.14%	24,452 $26,000
Q1 2024 May 13, 2024	SELL	$0.92 - $1.44 $234,784 - $367,488	-255,200 Reduced 67.46%	123,100 $152,000
Q4 2023 Feb 13, 2024	BUY	$0.64 - $6.49 $242,112 - $2.46 Million	378,300 New	378,300 $397,000
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $178,021 - $228,210	12,423 New	12,423 $195,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.